| Peptide | Current significance |
| BPC-157 | 🔥 Major FDA/regulatory development |
| KPV | 🔥 Major FDA/regulatory development |
| TB-500 | 🔥 Under active regulatory consideration |
| MOTS-c | 🔥 Significant regulatory/research interest |
| GHK-Cu | 👀 Regulatory status worth watching |
| Epitalon | 👀 FDA review/compounding discussion |
| DSIP | 👀 FDA review/compounding discussion |
| Semax | 👀 FDA review/compounding discussion |
| Retatrutide | 🔥 Major clinical/weight-loss interest, but unapproved |
| CJC-1295/Ipamorelin | Ongoing demand, but regulatory concerns remain |
| LL-37 | Research interest; regulatory status worth monitoring |